Cargando…

Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects

Polycystic ovary syndrome (PCOS) is a common disorder with a high phenotypic variability. Frequently, it is associated with a mild to moderate insulin resistance (IR) caused by an interaction between polygenic diathesis and the environment. However, PCOS may be a complication of an underlying syndro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gambineri, Alessandra, Zanotti, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Special Issue on Laminopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000141/ https://www.ncbi.nlm.nih.gov/pubmed/30131000 http://dx.doi.org/10.1080/19491034.2018.1509659

Ejemplares similares

Familial Partial Lipodystrophy (FPLD): Recent Insights
por: Bagias, Christos, et al.
Publicado: (2020)

Clinical aspects of Emery-Dreifuss muscular dystrophy
por: Madej-Pilarczyk, Agnieszka
Publicado: (2018)

Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives
por: Vigouroux, Corinne, et al.
Publicado: (2018)

Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes
por: Bernasconi, Pia, et al.
Publicado: (2018)

An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
por: Harhouri, Karim, et al.
Publicado: (2018)

Invertebrate models of lamin diseases
por: Rzepecki, Ryszard, et al.
Publicado: (2018)

Laminopathy-causing lamin A mutations reconfigure lamina-associated domains and local spatial chromatin conformation
por: Briand, Nolwenn, et al.
Publicado: (2018)

Lipodystrophic laminopathies: Diagnostic clues
por: Guillín-Amarelle, Cristina, et al.
Publicado: (2018)

Causes and consequences of genomic instability in laminopathies: Replication stress and interferon response
por: Graziano, Simona, et al.
Publicado: (2018)

Mechanotransduction, nuclear architecture and epigenetics in Emery Dreifuss Muscular Dystrophy: tous pour un, un pour tous
por: Bianchi, Andrea, et al.
Publicado: (2018)

Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2018)

Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease
por: Peretto, G., et al.
Publicado: (2018)

Up-regulation of Toll-like receptors 7 and 9 and its potential implications in the pathogenic mechanisms of LMNA-related myopathies
por: Cappelletti, Cristina, et al.
Publicado: (2018)

Genomic instability and DNA replication defects in progeroid syndromes
por: Burla, Romina, et al.
Publicado: (2018)

Analysis of RNA-Seq datasets reveals enrichment of tissue-specific splice variants for nuclear envelope proteins
por: Capitanchik, Charlotte, et al.
Publicado: (2018)

MON-695 Multiple Recurrent Lipomatoses with Thiazolidinedione Therapy in Familial Partial Lipodystrophy, Dunnigan Variety (FPLD2)
por: Patni, Nivedita, et al.
Publicado: (2020)

Peroxisomal proliferator activated receptor-γ deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)
por: Francis, Gordon A, et al.
Publicado: (2006)

SUN-135 Dual Energy X-Ray Absorptiometry (DEXA) as a Diagnostic Tool for Familial Partial Lipodystrophy, Dunnigan Variety (FPLD2)
por: Vasandani, Chandna, et al.
Publicado: (2019)

Familial Partial Lipodystrophy—Literature Review and Report of a Novel Variant in PPARG Expanding the Spectrum of Disease-Causing Alterations in FPLD3
por: Rutkowska, Lena, et al.
Publicado: (2022)

Describing the natural history of clinical, biochemical and radiological outcomes of children with familial partial lipodystrophy type 2 (FPLD2) from the United Kingdom: A retrospective case series
por: Zhong, Zhu Xuan, et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction
por: Schena, Elisa, et al.
Publicado: (2023)

Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study
por: Foss-Freitas, Maria C., et al.
Publicado: (2021)

Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning
por: Pellegrini, Camilla, et al.
Publicado: (2019)

Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C
por: Cecchetti, Carolina, et al.
Publicado: (2021)

Molecular and Mechanobiological Pathways Related to the Physiopathology of FPLD2
por: Varlet, Alice-Anaïs, et al.
Publicado: (2020)

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
por: Pandurevic, Srdan, et al.
Publicado: (2021)

Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution
por: Capanni, Cristina, et al.
Publicado: (2012)

Personality and Psychiatric Disorders in Women Affected by Polycystic Ovary Syndrome
por: Scaruffi, Elisabetta, et al.
Publicado: (2014)

Type 2 Diabetes With Partial Lipodystrophy of the Limbs: A new lipodystrophy phenotype
por: Strickland, Leah R., et al.
Publicado: (2013)

Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
por: Livadas, Sarantis, et al.
Publicado: (2023)

Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes: Results From a Long-Term Prospective Study
por: Gambineri, Alessandra, et al.
Publicado: (2012)

Evaluation of epicardial adipose tissue in familial partial lipodystrophy
por: Godoy-Matos, Amélio Fernando, et al.
Publicado: (2015)

SUN-556 Cardiac Phenotype in Familial Partial Lipodystrophy
por: Eldin, Abdelwahab Jalal, et al.
Publicado: (2020)

The polycystic ovary syndrome: the first 150 years of study
por: Adashi, Eli Y., et al.
Publicado: (2022)

Lamin A, Chromatin and FPLD2: Not Just a Peripheral Ménage-à-Trois
por: Briand, Nolwenn, et al.
Publicado: (2018)

Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
por: Jéru, Isabelle, et al.
Publicado: (2019)

DNA repair-related genes and adipogenesis: Lessons from congenital lipodystrophies
por: Campos, Julliane Tamara Araújo de Melo, et al.
Publicado: (2022)

Technical aspects of surgical correction of spinal deformities in cerebral palsy
por: Mineiro, Jorge, et al.
Publicado: (2020)

Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy
por: Algieri, Cristina, et al.
Publicado: (2022)

Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review
por: Fernandez-Pombo, Antia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_74aeqavpakgin64n4aofrpe14f